Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >p19 INK4d Protein, Human, Recombinant (GST)
p19 INK4d Protein, Human, Recombinant (GST)
  • p19 INK4d Protein, Human, Recombinant (GST)

p19 INK4d Protein, Human, Recombinant (GST) NEW

Price $413
Package 50μg
Min. Order:
Supply Ability: 10g
Update Time: 2025-08-29

Product Details

Product Name: p19 INK4d Protein, Human, Recombinant (GST) Supply Ability: 10g
Release date: 2025/08/29

Product Introduction

Bioactivity

Namep19 INK4d Protein, Human, Recombinant (GST)
DescriptionCyclin-dependent kinase inhibitor 2D(also known as CDKN2D or p19ink4d), a member of the INK4 family of cyclin-dependent kinase (CDK) inhibitors, negatively regulates the cyclin D-CDK4/6 complexes, which promote G1/S transition by phosphorylating the retinoblastoma tumor-suppressor gene product. It is clearly shown that DNA repair is the main target of p19ink4d effect and that diminished apoptosis is a downstream event. Experiments has uncovered a role of p19INK4d as a regulator of DNA-damage-induced apoptosis and suggest that it protects cells from undergoing apoptosis by allowing a more efficient DNA repair. It has been demonstrated that p19INK4d expression enhances cell survival under genotoxic conditions. Previous work has shown that inactivation of the cyclin-dependent kinase inhibitor (CKI) p19(Ink4d) leads to progressive hearing loss attributable to inappropriate DNA replication and subsequent apoptosis of hair cells. It may also involved in male reproductive function including testicular atrophy, alteration in serum follicle stimulating hormone, qualitative increase in germ cell apoptosis, and delayed kinetics of meiotic prophase markers.
StorageShipping with blue ice/Shipping at ambient temperature.
Keywordsp19, inhibits CDK4 | cyclin-dependent kinase inhibitor 2D

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

Recommended supplier

Product name Price   Suppliers Update time
$1680.00/1mg
VIP2Y
TargetMol Chemicals Inc.
2025-08-21
$1830.00/1mg
VIP6Y
TargetMol Chemicals Inc.
2025-08-28
$0.00/10Box
VIP2Y
Shandong Hanjiang Chemical Co., Ltd
2024-10-12

TargetMol Chemicals Inc.

4YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY